How Does Erlonat 150mg Work

Erlonat 150 mg (erlotinib) works by targeting and inhibiting a protein called the epidermal growth factor receptor (EGFR), which plays a crucial role in the growth and spread of cancer cells. EGFR is a cell surface receptor that, when activated by its natural ligands (such as epidermal growth factor), triggers a series of signals inside the cell that promote cell division and survival. This signaling pathway is often overactive in many types of cancer, including non-small cell lung cancer (NSCLC) and pancreatic cancer, leading to uncontrolled cell growth and tumor progression.

Benefits Of Erlonat 150mg

Erlonat 150 mg (erlotinib) offers several significant benefits, particularly for patients with non-small cell lung cancer (NSCLC) and pancreatic cancer. It is highly effective in treating advanced or metastatic NSCLC, especially in patients whose cancer cells have mutations in the epidermal growth factor receptor (EGFR) gene. By inhibiting the EGFR signaling pathway, Erlonat helps slow down the growth of cancer cells, improving survival rates and progression-free survival.
Common Side Effects:

The most common side effects of Erlonat 150mg are
• Rash (often acne-like)
• Diarrhea
• Fatigue
• Loss of appetite
• Nausea
• Mouth sores or ulcers
• Dry skin
• Itching
• Cough
• Shortness of breath

Other side effects of Erlonat 150mg can include
• Severe skin reactions (e.g., blistering, peeling, or redness)
• Liver problems (elevated liver enzymes, jaundice, or liver failure)
• Severe diarrhea or dehydration
• Eye problems (e.g., eye irritation, dryness, or inflammation)
• Respiratory issues (e.g., shortness of breath, lung infection, or pneumonia)
• Severe gastrointestinal bleeding
• Severe headache or dizziness
• Swelling in the legs or feet (edema)
• Chest pain or irregular heartbeat
• Severe fatigue or weakness
• Low blood cell counts (e.g., anemia, leukopenia, thrombocytopenia)
• Changes in kidney function

Who Should Not Take Erlonat 150mg

Erlonat 150 mg (erlotinib) should not be taken by individuals who are allergic to erlotinib or any of its ingredients. It is also contraindicated in patients with severe liver disease or severe liver impairment as it can worsen liver function and may lead to serious complications. Additionally, pregnant women or those who are planning to become pregnant should avoid taking Erlonat, as it can harm the developing fetus. It is also not recommended for breastfeeding women due to potential harm to the infant.

How To Take Erlonat 150mg

Erlonat 150 mg (erlotinib) should be taken exactly as prescribed by your healthcare provider. It is usually taken once daily, at the same time each day, to maintain consistent levels of the medication in your body. The tablet should be swallowed whole with a full glass of water and should not be crushed, chewed, or broken. It is best taken on an empty stomach, either at least 1 hour before or 2 hours after a meal, to ensure optimal absorption.